Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA operates as a subsidiary of Soparfin SCA.
Frequently asked questions
What sector does Vetoquinol Ord (VETOF) operate in?
Vetoquinol Ord belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Vetoquinol Ord (VETOF) current stock price?
As of the latest data, Vetoquinol Ord stock price is $88.19, with a previous close of $88.19.
What is Vetoquinol Ord (VETOF) current market capitalization?
Vetoquinol Ord market cap is approximately 1.03 billion.
What is Vetoquinol Ord (VETOF) Earnings Per Share (EPS)?
The trailing EPS is $6.35.
What is Vetoquinol Ord (VETOF) Price-to-Earnings (P/E) ratio?
Vetoquinol Ord current P/E ratio is 13.89.
Does Vetoquinol Ord (VETOF) pay dividends?
Yes. Vetoquinol Ord pays annual dividends with an annualized yield of 1.23% and an estimated annual payout of $1.08 per share.
When is the next ex-dividend date for Vetoquinol Ord (VETOF)?
The next ex-dividend date is scheduled for June 04, 2027.
What is Vetoquinol Ord (VETOF) beta (volatility) score?
Vetoquinol Ord has a beta of 0.830, meaning its volatility is roughly in line with the market.